Oral melphalan, prednisone,thalidomide versus oral melphalan, prednisone in elderly newly diagnosed myeloma patients

被引:0
|
作者
Palumbo, A.
Bringhen, S.
Caravita, T.
Falcone, A.
Callea, V.
Cangialosi, C.
Grasso, M.
Galli, M.
Rossini, F.
Catalano, L.
Montanaro, M.
De Stefano, V.
Magarotto, V.
Avonto, I.
Musto, P.
Liberati, A. M.
Cavo, M.
Boccadoro, M.
机构
[1] Az Osp S Giovanni Battista, Turin, Italy
[2] Univ Roma Tor Vergata, Rome, Italy
[3] IRCCS Casa Sollievo Sofferenza, San Giovanni Rotondo, Italy
[4] Osped Riuniti Reggio Calabria, Reggio Di Calabria, Italy
[5] Az Osp Cervello, Palermo, Italy
[6] Az Osp S Croce & Carle, Cuneo, Italy
[7] Osped San Gerardo, Monza, Italy
[8] Univ Naples Federico II, Naples, Italy
[9] Osped S Anna, Ronciglione, Italy
[10] Univ Cattolica, Rome, Italy
[11] Ctr Riferimento Oncol Basilicata, Rionero In Vulture, Italy
[12] Monteluce Policlin, Perugia, Italy
[13] Univ Bologna, Ist Seragnoli, Bologna, Italy
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
0401
引用
收藏
页码:147 / 147
页数:1
相关论文
共 50 条
  • [1] A prospective randomized controlled trial of oral melphalan, prednisone, thalidomide versus oral melphalan, prednisone in elderly newly diagnosed myeloma patients
    Palumbo, A.
    Aitoro, G.
    Bringhen, S.
    Caravita, T.
    Callea, V.
    Zambello, R.
    Pregno, P.
    Carubelli, A.
    Baraldi, A.
    Cellini, C.
    Dore, F.
    Piro, E.
    Ambrosini, M. T.
    Musto, P.
    Liberati, A. M.
    Boccadoro, M.
    ANNALS OF ONCOLOGY, 2006, 17 : VII161 - VII161
  • [2] Oral melphalan, prednisone, and thalidomide for newly diagnosed patients with myeloma
    Palumbo, A
    Bertola, A
    Musto, P
    Caravita, T
    Callea, V
    Nunzi, M
    Grasso, M
    Falco, P
    Cangialosi, C
    Boccadoro, M
    CANCER, 2005, 104 (07) : 1428 - 1433
  • [3] Oral melphalan, prednisone and thalidomide for newly diagnosed myeloma patients.
    Palumbo, A
    Bertola, A
    Musto, P
    Nunzi, M
    De Stefano, V
    Catalano, L
    Caravita, T
    Cangialosi, C
    Bringen, S
    Boccadoro, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 569S - 569S
  • [4] Oral melphalan, prednisone and thalidomide for newly diagnosed myeloma.
    Palumbo, A
    Bertola, A
    Musto, P
    Nunzi, M
    De Stefano, V
    Callea, V
    Rotoli, B
    Petti, MC
    Caravita, T
    Lauta, VM
    Patti, C
    Bringhen, S
    Cavallo, F
    Falco, P
    Carella, AM
    Liberati, AM
    Boccadoro, M
    BLOOD, 2003, 102 (11) : 148A - 148A
  • [5] Prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) for newly diagnosed elderly myeloma
    Renaud, Loic
    Leleu, Xavier
    HEMATOLOGIE, 2014, 20 (03): : 138 - 138
  • [6] Melphalan, prednisone and thalidomide in newly diagnosed myeloma
    Palumbo, A.
    Bringhen, S.
    Caravita, T.
    Falcone, A.
    Callea, V.
    Petrucci, M. T.
    Morandi, S.
    Capaldi, A.
    Lauta, V. M.
    Pisani, F.
    Zambello, R.
    Pregno, P.
    Magarotto, V.
    Avonto, I.
    Musto, P.
    Liberati, A. M.
    Boccadoro, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 176 - 176
  • [7] Oral melphalan, prednisone and lenalidomide treatment for newly diagnosed elderly multiple myeloma patients
    Falco, F.
    MT, Petrucci
    Corradini, P.
    Crippa, C.
    Di Raimondo, F.
    Falcone, A.
    Guiliani, N.
    Musto, P.
    Ruggeri, M.
    Larocca, A.
    D'Agostino, F.
    Canepa, L.
    Gozzetti, A.
    Morabito, F.
    Knight, R.
    Zeldis, J. B.
    Boccadoro, M.
    Palumbo, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 31 - 31
  • [8] Oral melphalan, prednisone and thalidomide for multiple myeloma.
    Palumbo, A
    Bringhen, S
    Musto, P
    Caravita, T
    Capozzi, R
    Callea, V
    Cangialosi, C
    Montanaro, M
    Catalano, L
    Grasso, M
    Petti, MC
    Merla, M
    Falchi, L
    Omedè, P
    Ceccarelli, M
    Ambrosini, MT
    Avonto, I
    Gay, F
    Falco, P
    Boccadoro, M
    BLOOD, 2005, 106 (11) : 230A - 230A
  • [9] Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study
    Morabito, Fortunato
    Bringhen, Sara
    Larocca, Alessandra
    Wijermans, Pierre
    Victoria Mateos, Maria
    Gimsing, Peter
    Mazzone, Carla
    Gottardi, Daniela
    Omede, Paola
    Zweegman, Sonja
    Jose Lahuerta, Juan
    Zambello, Renato
    Musto, Pellegrino
    Magarotto, Valeria
    Schaafsma, Martijn
    Oriol, Albert
    Juliusson, Gunnar
    Cerrato, Chiara
    Catalano, Lucio
    Gentile, Massimo
    Isabel Turel, Ana
    Liberati, Anna Marina
    Cavalli, Maide
    Rossi, Davide
    Passera, Roberto
    Rosso, Stefano
    Beksac, Meral
    Cavo, Michele
    Waage, Anders
    San Miguel, Jesus
    Boccadoro, Mario
    Sonneveld, Pieter
    Palumbo, Antonio
    Offidani, Massimo
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (04) : 355 - 362
  • [10] A Prospective, Randomized, Phase III Study of Bortezomib, Melphalan, Prednisone and Thalidomide (VMPT) Versus Bortezomib, Melphalan and Prednisone (VMP) in Elderly Newly Diagnosed Myeloma Patients
    Palumbo, Antonio
    Bringhen, Sara
    Rossi, Davide
    Magarotto, Valeria
    Di Raimondo, Francesco
    Ria, Roberto
    Offidani, Massimo
    Nozzoli, Chiara
    Patriarca, Francesca
    Callea, Vincenzo
    Benevolo, Giulia
    Marasca, Roberto
    Guglielmelli, Tommasina
    Rizzo, Manuela
    Grasso, Mariella
    Petrucci, Maria Teresa
    Omede, Paola
    Gaidano, Gianluca
    Boccadoro, Mario
    BLOOD, 2008, 112 (11) : 243 - 243